ABSTRACT
OriginalA
rticle
INTRODUCTION
Fibromyalgia is a rheumatic syndrome thatcanbecharacterizedbychronicanddif-fusemusculoskeletalpain,andalsobyalow pain threshold at specific anatomical points named tender points.The syndrome is also oftenassociatedwithothersymptomssuchas fatigue, sleep disturbance, morning stiffness1 andoccasionallywithdyspneaandanxiety.2-5 Thesyndromemostlyaffectswomenbetween 40and55yearsold.
Themainsymptominfibromyalgiaisdif-fuseandchronicpain.Sometimesthepaincan besoseverethatitinterferesintheindividual’s work,day-to-dayactivitiesandqualityoflife.6-8 Thechronicpaincausesacomponentofsuf-fering, with many contributory factors such asanxiety,frustrationandanger;italsohasan adverse impact on the person’s mood.9 Such symptomsleadtodisabilityandenduphaving anegativeimpactonthepatient’slife.10 There-fore,itisimportanttomeasurethisimpact.
Anxiety is an important factor to be takenintoconsiderationwhentalkingabout fibromyalgia.11,12Inonestudydevelopedby Yunusetal.,70%ofthepatientsconsidered themselvesanxious,andin68%ofthepatients thesymptomswereworsenedduetoanxiety andmentalstress.13
The use of quality of life assessment instruments and questionnaires has been recognizedasanimportantsourceofscientific knowledgeinthehealthcarefield.Inclinical practice,theycanidentifypatients’needsand assessinterventioneffectiveness.
Qualityoflifeassessmentinstrumentscan begenericorspecific.In1991,Burckhardtet
al.14 proposed and tested an instrument for assessing quality of life in fibromyalgia, the Fibromyalgia Impact Questionnaire (FIQ). TheyconcludedthatFIQisvalidtobeused inresearchorclinicalsituations.
Whiteetal.,10usingFIQ,reportedthat fibromyalgiacausedanegativeimpactonthe qualityoflifeofpatientsofaneconomically productiveage.Thisresultedfromsymptoms such as fatigue and subjective weakness, in addition to pain.These symptoms caused disabilitythatcontributedtowardstheseindi-viduals’incapacitytoworkandconsequently resultedinreducedfamilyincomeandwors-enedqualityoflife.
A generic instrument for quality of life assessmentthatiswidelyusedistheMedical Outcomes Study 36-item Short-Form Health Survey(SF-36).15 Itwastranslatedandvali-datedforuseinPortuguesebyCiconelli16and hasbeenusedasagenericmeasureforquality oflifeassessmentinothersituations,suchas kneearthroplasty,17rheumatoidarthritis16and osteoarthritis.18
Anxiety,mentionedbysomeauthors11,12 as one of the symptoms in fibromyalgia, canbemeasuredbytheState-TraitAnxiety Inventory (STAI). STAI was proposed by Spielberger and Gorsuch19 in 1964, with theintentionofgeneratingadirectresearch instrumentforself-evaluationthatcouldbe usedtomeasuretraitsandstatesofanxiety amongnormaladults.20
PURPOSE
Theobjectiveofthisstudywastoassess thequalityoflifeandanxietyleveloffibromy-algiapatients,usingFIQ,SF-36andSTAI.
andqualityoflifein
fibromyalgiapatients
Rheumatologyclinic,HospitaldasClínicas,FaculdadedeMedicinada
UniversidadedeSãoPaulo,SãoPaulo,Brazil
•AméliaPasqualMarques
•CarlosAlbertodeBragançaPereira
CONTEXT:Fibromyalgiaisasyndromecharacterized bychronic,diffusemusculoskeletalpain,andbya lowpainthresholdatspecificanatomicalpoints. Thesyndromeisassociatedwithothersymptoms suchasfatigue,sleepdisturbance,morningstiffness andanxiety.Becauseofitschronicnature,itoften hasanegativeimpactonpatients’qualityoflife.
OBJECTIVE:Toassessthequalityoflifeandanxietylevel ofpatientswithfibromyalgia.
TYPEOfSTUDY:Cross-sectional.
SETTING:RheumatologyoutpatientserviceofHospital das Clínicas (Medical School, Universidade de SãoPaulo).
METHODS: Thisstudyevaluated80individuals,dividedbe-tweentestandcontrolgroups.Thetestgroupincluded 40womenwithaconfirmeddiagnosisoffibromyalgia. Thecontrolgroupwascomposedof40healthywomen. Threequestionnaireswereused:twotoassessqualityof life(FIQandSF-36)andonetoassessanxiety(STAI). Theywereappliedtotheindividualsinbothgroupsin asingleface-to-faceinterview.Thestatisticalanalysis usedStudent’sttestandPearson’scorrelationtest(r), withasignificancelevelof95%.Also,thePearson chi-squaredstatisticstestforhomogeneity,withYates correction,wasusedforcomparingschoolingbetween testandcontrolgroups.
RESULTS:Therewasastatisticallysignificantdifference betweenthegroups(p=0.000),thusindicatingthat fibromyalgiapatientshaveaworsequalityoflifeand higherlevelsofanxiety.Thecorrelationsbetweenthe threequestionnaireswerehigh(r=0.9).
DISCUSSION:Thisstudyhasconfirmedtheefficacyof FIQ for evaluating the impact of fibromyalgia on thequalityoflife.SF-36islessspecificthanFIQ, althoughstatisticallysignificantvalueswereobtained whenanalyzedseparately,STAIshowedlowereffi-cacyfordiscriminatingthetestgroupfromthecontrol group.Thetestgroupshowedworsequalityoflife thandidthecontrolgroup,whichwasdemonstrated bybothFIQandSF-36.EventhoughSTAIwasaless efficientinstrument,itpresentedsignificantresults, showingthatfibromyalgiapatientspresentedhigher levelsofanxiety,bothonthestateandtraitscales. Thus,patientswithfibromyalgiahadhigherlevelsof tension,nervousness,preoccupationandapprehen-sion,andhigherpropensitytowardsanxiety.
CONCLUSION:Thethreeinstrumentsutilizedshowed efficiencyinevaluatingfibromyalgiapatients.FIQ wasfoundtobethemostefficientinstrumentfor discriminatingandassessingtheimpactoffibro-myalgiaontheirqualityoflife.Itcanbeconcluded thatsuchpatientshaveaworsequalityoflifeand higherlevelsofanxiety.
METHODS
Subjects–The study included 80 in-dividuals. Forty of them had a diagnosis of fibromyalgia according to the American CollegeofRheumatologycriteria,1recruited from the Rheumatology outpatient service ofHospitaldasClínicas,MedicalSchoolof UniversidadedeSãoPaulo,andtheother40 were healthy individuals forming a control group.Thesubjectswereselectedaccording to the following criteria: age between 35 and 60 years; adequate cognitive level for understandingtheproceduresandfollowing theguidancegiven;agreementtoparticipate in the study; and signing of the informed consentdocument.
Setting -The study was performed by thePhysicalTherapyDepartment,withinthe RheumatologyoutpatientserviceofHospital das Clínicas, Medical School, Universidade deSãoPaulo.
Procedures–Alltheindividualsinboth groupswereevaluatedatasingleface-to-face interview.Thefollowingdatawasobtained: personal data (age, sex, race, weight and height);previousandpresentoccupation;level ofeducation;maritalstatus;historyofpain: whenithadoccurred,painfulsitesonthebody (indecreasingorderofintensity),periodof thedaywhenitwasmostsevereandfactors thatwouldincreaseordecreasethepain;and their quality of sleep and mattress and pil-lowtype.Becauseofpatients’difficultiesin reading,theinvestigatorsdecidedtoreadthe questionnairesalongwiththem.
Quality of life assessment was done by meansofthefollowinginstruments: Fibromy-algia Impact Questionnaire(FIQ),14Medical Outcomes Study 36-item Short-Form Health Survey(SF-36)15and State-TraitAnxietyInven-tory(STAI).19FIQinvolvesquestionsrelatedto functionalcapacity,professionalsituation,psy-chologicaldisturbancesandphysicalsymptoms. Thehigherthescore,thehighertheimpactof fibromyalgiaisonqualityoflife.SF-36isage-nericmultidimensionalinstrumentthatassesses eightcharacteristics:functionalcapacity,physical characteristics,pain,generalhealth,vitality,social andemotionalcharacteristicsandmentalhealth. Inaddition,anxietywasassessedusingSTAI, whichevaluatestraitsandstatesofanxiety.STAI consistsoftwodistinctanxietyscales:traitscale (A-trait)andstatescale(A-state).Bothscalesare composedof20questionsandrequirethatthe subjectsdescribehowtheyfeelgenerically,on theA-traitscale,andhowtheyfeelataspecific moment,ontheA-statescale.
Table1.Demographicdataof80participantsinastudyonfibromyalgia inSãoPaulo(40patientsand40controls)
Controlgroup Testgroup
Mean/SD Mean/SDp
Age(years) 49.48±7.65 49.43±5.950.97 Weight(kg) 65.25±12.73 67.62±13.620.42 Height(m) 1.60±0.06 1.58±0.070.27 BMI(kg/m2) 25.29±4.39 26.93±5.060.12
Schooling: Noeducation
Incompleteelementaryschool Completedelementaryschool Incompletehighschool Completedhighschool College
FemaleSex
0% 2.5% 17.5%
10% 30% 40% 100%
5% 27.5% 17.5% 12.5% 25% 12.5% 100%
SD=standarddeviation;BMI=bodymassindex.Note:inBrazil,elementaryschoolcompriseseightyearsandhighschool,thefollowingthree.
Table2.DatafromtheFibromyalgiaImpactQuestionnaire(FIQ)applied to40patientswithfibromyalgiaand40controlsinSãoPaulo
Variables Controlgroup Testgroup“t”test
Mean±SD Mean±SDtp 1)Physicalfunction 4.35±5.16 14.93±5.378.980.00 2)Feelingwell 6.33±1.53 1.93±1.8511.620.00 3)Workmissed 0±0 0± 0--------4)Jobability 0.2±0.65 7.36±2.0221.330.00 5)Pain 0.66±1.46 7.77±1.7219.90.00 6)Fatigue 2.37±2.99 7.7±2.219.030.00 7)Morningtiredness 1.39±2.5 7.18±2.89.750.00 8)Stiffness 0.16±0.82 6.97±2.4716.540.00 9)Anxiety 3.54±3.4 7.71±2.686.090.00 10)Depression 1.7±2.34 6.23±3.267.140.00
Forα=0.05,“t”(tα/2)=2.10.
Statisticalanalysis–Thestatisticalanaly-ses used Student’s t statistics for comparing groups and for testing Pearson correlations. Also, the Pearson Chi-squared statistics test forhomogeneity,withYatescorrection,was used for comparing scholarity betweenTest andControlgroups.Toavoidworkingdirectly withallthequestionnaireitems,wereduced their dimensions to real numerical values. We named these reductions the quality of lifeindices.TheFIQandSF-36reductions were called FIQI and SFI, respectively. In addition, there are differences between the twoquestionnairesregardingthefinalscore evaluation:forFIQ,thehigherthefinalvalue, theworsethequalityoflifeis;andforSF-36, thehigherthefinalvalue,thebetterthequality oflifeis.ToconstructFIQI,sevenitemswere takenintoconsideration(variablesevaluated by the instrument), while eight items were considered for SFI. FIQI was calculated as 10minusthemeanofthesevenitems,while SFIwascalculatedasthemeanoftheeight items,dividedby10.Bydoingthis,bothFIQI andSFIvaryfrom0to10,andbothindicate
thatthehighertheirvaluesare,thebetterthe qualityoflifeis.ThesamewasdoneforSTAI, forwhichtheindexwascalledIDI,sothat comparisons between the three instruments wouldbepossible.
Finally, to illustrate the results described above, we constructed a dispersion diagram fortheindexes,therebyemphasizingthetwo groups. On the same diagram, we plotted a diagonallinethatcontainsthepointswherethe indicesareequal.
Results
Questionnaireevaluation
Thethreequestionnaireswereappliedtoall subjects,thustotaling240questionnaires.The resultsobtainedareshowninTables2,3and4.
The results obtained via FIQ (Table 2) showedstatisticallysignificantdifferencesbe- tweenthecontrolandthetestgroups,forallvari-ables.Theonlyexceptionwasthevariable“work missed”,sincebothgroupshadzerovalues.
Table3showstheresultsobtainedviaSF-36. Therewerestatisticallysignificantdifferencesbe-tweenthecontrolandtestgroupsforallvariables. Onlythevariable“role-emotional”hadalower valuethantheothers,althoughitstillshoweda statisticallysignificantdifference.
The results obtained via STAI (Table 4) showed a statistically significant difference betweenthecontrolandtestgroups.Variables suchas“anxietystate”and“anxietytrait”had highermeanvaluesinthetestgroupthaninthe controlgroup.Therewasnointra-groupdiffer-encebetweenSTAItraitandSTAIstate.
Questionnaireefficacyevaluation
Tobetterillustratetheresultsshownin Tables2,3and4,dispersiondiagramswere constructedbetweenFIQIandSFI,between FIQIandIDIand,finally,betweenSFIand IDI.Inthesediagrams,adiagonallinewas tracedoutwherethepointsareequal:FIQI=
Table3.DatafromtheMedicalOutcomesStudy36-itemShortFormHealthSurvey(SF-36)appliedto40patientswithfibromyalgiaand40controlsinSãoPaulo
Variables Controlgroup Testgroup“t”test Mean±SD Mean±SDtp
1)Physicalfunction 86.63±16.5 33.00±19.5713.250.00 2)Role-physical 90.00±22.5 9.38±22.4216.050.00 3)Bodypain 76.65±20.78 30.23±14.8311.50.00 4)Generalhealth 81.47±17.78 45.65±21.658.090.00 5)Vitality 67.93±20.37 33.13±21.267.470.00 6)Socialfunction 82.94±22.38 44.00±26.487.110.00 7)Role-emotional 77.53±37.27 30.83±38.795.490.00 8)Mentalhealth 75.7±14.84 45.6±22.137.140.00
Forα=0.05,“t”(tα/2)=2.10.
Table4.DatafromtheState-TraitAnxietyInventory(STAI))appliedto40patientswith fibromyalgiaand40controlsinSãoPaulo
Anxietyvariable Controlgroup Testgroup“t”test Mean±SD Mean±SDtp
Anxiety-state 35.13±12.11 51.88±11.686.300.00
Anxiety-trait 36.78±9.44 53.18±12.66.600.00 Forα=0.05,“t”(tα/2)=2.10.
Figure1.DispersionofresultsbetweentheFibromyalgiaImpactQuestionnaireIndex(FIQI)andtheMedicalOutcomesStudy 36-itemShortFormHealthSurvey(SF-36)Index(SFI)inasampleof80individualsinSãoPaulo.
SFI,FIQI=IDIandSFI=IDI.
Figure 1 shows the dispersion for FIQI versusSFI.Itcanbeseenthatthecontrolgroup ismorehomogeneousthanthetestgroup,since itsvaluesareclosertotheline.Thedispersionin thecontrolgroupissmaller,sinceitsvariation limitsareseentobemorerestrictedthanforthe testgroup.Thepointsforthecontrolgroupare concentratedintheupperrightpartofthegraph, therebyindicatingthattheyarehigh-valuepoints forFIQIaswellasforSFI.Ontheotherhand, thepointsforthetestgroupsareconcentrated inthelowerleftpartofthegraph,therebyindi-catinglowervaluesforFIQIaswellasforSFI. Incomparingthedispersionresultswithinthe samegroup,itisnoticeablethatthedispersion issmallerinFIQIthaninSFI.
Figure 2 shows the dispersion graph for FIQIversusIDI.Twodifferentpopulationscan bedistinguished:oneconcentratedmostlyinthe upperrightquadrant,representingthecontrol group;andanotherone,concentratedinthelower leftquadrant,representingthetestgroup.Thetest grouppresentslowervaluesviabothinstruments (FIQandSTAI).Theoppositeisseenforthe controlgroup.Incomparingthedispersionresults withinthesamegroup,itisnoticeablethatthe dispersionissmallerinFIQIthaninIDI.
Figure3showsthedispersiongraphfor SFIversusIDI.Itcanbeseenthatthereisa slightconcentrationofthecontrolgroupin thelowerrightquadrant,whilethetestgroup isconcentratedintheupperleftquadrant. ThetestgrouphaslowervaluesforSFIaswell forIDI,andgreaterdispersiononthegraph thandoesthecontrolgroup.Incomparing thedispersionresultswithinthesamegroup, itisnoticeablethatthedispersionissmaller inSFIthaninIDI.Thepointsthatarebelow thelinehavelowerpowerfordiscriminating fibromyalgia.
DISCUSSION
Thenegativeimpactonthequalityoflife causedbyfibromyalgiahasbeenreportedfrom manytrialsinwhichassessmentprotocolswere themajorevaluationinstruments.21-24
FIQisaninstrumentthathasbeenused invariousclinicaltrialsforassessingphysical function.Italsohelpsinthemeasurementof theefficacyofthetherapeuticinterventionin fibromyalgiacases,andithasbeenspecifically validatedforassessingthequalityoflifeamong fibromyalgiapatients/individuals.14
TrialsthatusedFIQastheassessmentpro- tocolhaveattestedtoitsefficacyinmakingcom-parisonswithhealthysubjects21andwithsubjects affectedbyotherdiseases,24,25aswellasbetween fibromyalgiapatientsbeforeandaftertreatment programs,includingphysicaltherapy,26-30and inprospectivetrials.31Similarly,thisstudyhas confirmedtheefficacyofFIQforevaluatingthe impactoffibromyalgiaonthequalityoflife.
SF-36 is another questionnaire that as-sessesqualityoflife,butitislessspecificthan FIQ.Itiscapableofassessingtherelationship between health status and quality of life: its eight subscales have a high correlation with functional disability.The majority of these subscales represent aspects of health that are importantforfibromyalgiapatientsorthedif-fusenessofthepain.Thegravityoffunctional impairment,asassessedbySF-36,differentiates suchpatientsfromnormalindividuals,aswell as differentiating patients with fibromyalgia fromthosewithdiffusepainonly.TheSF-36 questionnaireisalsoefficientatassessingqual-ityoflifeamongfibromyalgiapatients,sinceit candistinguishhealthyindividualsfromthose withfibromyalgia,aspreviouslydescribedby Martinezetal.23
By assessing health status and physical function, these questionnaires alsoallow psychologicalevaluationofsuchpatients,for example,throughtheiranxietyanddepression subscales.32 Anxietyisconsideredtobeacom-monsecondarysymptomoffibromyalgia,and itisfrequentlysevereinfibromyalgiacases.25 Oneoftheinstrumentsusedforevaluating anxiety is STAI,19,25,33 which was proposed for measuring the trait (propensity towards anxiety)andthestate(tension,nervousness, preoccupationandapprehension)ofanxiety. STAI thus allows measurement of the level ofpsychologicaldisturbanceamongsubjects thatismainlyrelatedtoanxiety.Inthepres-ent study, although statistically significant valueswereobtainedwhentheywereanalyzed separately, STAI showed lower efficacy for discriminatingthetestgroupfromthecontrol
Figure2.DispersionofresultsbetweentheFibromyalgiaImpactQuestionnaireIndex(FIQI)andtheState-TraitAnxiety InventoryIndex(IDI)inasampleof80individualsinSãoPaulo.
Figure3.DispersionofresultsbetweentheMedicalOutcomesStudy36-itemShortFormHealthSurvey(SF-36)Index(SFI) andtheState-TraitAnxietyInventoryIndex(IDI)inasampleof80individualsinSãoPaulo.
group,incomparisonwithotherinstruments. Suchafindingisageneralreflectionofthefact thatbothpopulationspresentedconsiderable anxietylevels,whichmakesitmoredifficult tocharacterizethesubpopulationsonthebasis ofthesevariables.
Morespecificallyregardingqualityoflife, itwaspossibletoconfirmthatthetestgroup showedworsequalityoflifethandidthecon-trolgroup,whichwasdemonstratedbyboth instrumentsusedforassessingqualityoflife (FIQandSF-36).Thisresultiscomparable with what other studies have suggested, in whichpatientswithchronicdiseasessuchas fibromyalgia may have lower quality of life levelsthanseeninhealthypopulations.34
Withregardtoanxiety,eventhoughSTAI was a less efficient instrument, it presented significantresultsinassessingboththetestand
controlgroups,showingthatfibromyalgiapatients presentedhigherlevelsofanxiety,bothonthestate andtraitscales.Thus,patientswithfibromyalgia hadhigherlevelsoftension,nervousness,preoccu-pationandapprehension(assessedviatheA-state scale),andhigherpropensitytowardsanxiety (evaluatedviatheA-traitscale).
Figure4.Percentilesoftheresultsofqualityoflifeevaluationbythreequestionnairesappliedto40fibromyalgiapatientsand 40healthycontrols.FIQ=FibromyalgiaImpactQuestionnaire;SF-36=MedicalOutcomesStudy36-itemShortFormHealth Survey;STAI=State-TraitAnxietyInventory.FIQI-T=FIQIndex–Test;SFI-T=SF-36Index–Test;IDI-T=STAIIndex –Test;FIQI-C=FIQIndex–Control;SFI-C=SF-36Index–Control;IDI-C=STAIIndex–Control.
groupbetterandallowedbetterdiscrimination betweenthetestandthecontrolgroups.These findingscanbeseenillustratedinthedisper-sionandpercentilegraphs.Thisinstrument hasalreadybeenusedinothertrials,which atteststoitsefficacy.14,24,26-28
SF-36wasthesecondmosteffectiveinstru-mentindifferentiatingthetestgroupfromthe controlgroup,alsoonthebasisofthesegraphs. SF-36isaninstrumentforassessingthegeneric qualityoflife,anditevaluatesfunctionalcapac-ity,physicalcharacteristics,pain,generalhealth status,vitality,socialandemotionalcharacter-isticsandmentalhealth.Theresultsshowthat SF-36alsodemonstratedefficiencyinassessing thequalityoflifeoffibromyalgiapatients,with resultssimilartothosefoundbyCiconelli16and Dias18.Inanotherstudy,Brazilianwomenwith
fibromyalgiafromtheSorocabaregion,State ofSãoPaulo,werecomparedwithacontrol groupinrelationtoqualityoflifeeffects.In this,SF-36wasutilizedasanassessmenttool anditwasalsoconcludedthatthediseasehas anegativeimpactonqualityoflife.35
Thestrongcorrelationbetweenthethree questionnairesshowsthatallofthemarecapable of distinguishing subjects with fibromyalgia fromhealthyones.FIQwasthemostefficient questionnaireforcharacterizingfibromyalgia, followedbySF-36andthenSTAI(Figure4). ThissuggeststhatFIQmaybetheinstrumentof preferencewhenonlyassessingpopulationswith fibromyalgia.Thisresultwasexpected,sinceFIQ wasspeciallyconstructedforassessingpatients withfibromyalgia. Relatedtrials,inwhichSF-36 was compared to specific questionnaires,
havealsoreportedgreaterefficacyofthespecific questionnaire.Nevertheless,thediscriminatory capacityofSF-36mustbestressed.36,37
The results found in this trial have confirmedtheefficacyoftheinstrumentsin assessingthequalityoflifeandanxietyamong subjects with fibromyalgia.They have also reinforced the credibility of the question-nairesastoolsforassessingmultipleaspects of fibromyalgia and for following up these characteristics over a period of time and/or aftertherapeuticintervention. Theseinstru-ments may be important in comparative studiesamongpatientswithfibromyalgiaand otherdiseases,inrelationtohealthysubjects. Comparativestudiesofthisnatureareessential forestablishingtheimpactoffibromyalgiaon healthcaresystems andindrawingupexten-siveandinterdisciplinarytreatmentprograms forfibromyalgiapatients.Specificallyinthe fieldofphysicaltherapy,questionnairesallow theassessmentoftheresultsobtainedbythose plannedtreatments.
CONCLUSION
Thegroupofpatientswithfibromyalgia presentedworsequalityoflifewhencompared withthecontrolgroup.Thisshowedthatfibro-myalgiainterferesinqualityoflifeandanxiety levels,inrelationtotraitaswellastostateof anxiety, which suggests thatthese symptoms maybegeneratedbyfibromyalgia.
1. Wolfe F, Smythe HA,Yunus MB, et al.The American Col-legeofRheumatology1990CriteriafortheClassificationof Fibromyalgia.ReportoftheMulticenterCriteriaCommittee. ArthritisRheum.1990;33(2):160-72.
2. Caidahl K, Lurie M, Bake B, Johansson G, Wetterqvist H. Dyspnoea in chronic primary fibromyalgia. J Inter Med. 1989;226(4):265-70.
3. LurieM,CaidahlK,JohanssonG,BakeB.Respiratoryfunc-tioninchronicprimaryfibromyalgia.ScandJRehabilMed. 1990;22(3):151-5.
4. WeissDJ,KreckT,AlbertRK.Dyspnearesultingfromfibro-myalgia.Chest.1998;113(1):246-9.
5. Matsutani LA, Marques AP, Carvalho CRF, Ferreira EAG. DispnéianaFibromialgia.Inpress,2004.
6. MartinezJE,AtraE,FerrazMB,deSilvaPSB.Fibromialgia: aspectos clínicos e socioeconômicos. Rev Bras Reumatol. 1992;32(5):225-30.
7. WolfF,AarflotT,BruusgaardD,etal.Fibromyalgiaanddisability. ReportoftheMossInternationalWorkingGrouponmedico-legal aspectsofchronicwidespreadmusculoskeletalpaincomplaints andfibromyalgia.ScanJRheumatol.1995;24(2):112-8. 8.
HenrikssonC,BurckhardtC.Impactoffibromyalgiaonev-erydaylife:astudyofwomenintheUSAandSweden.Disabil Rehabil.1996;18(5):241-8.
9. GaskinME,GreeneAF,RobinsonME,GeisserME.Negative affect and the experience of chronic pain. J Psychosom Res. 1992;36(8):707-13.
10. WhiteKP,SpeechleyM,HarthM,OstbyeT.Comparingself-reportedfunctionandworkdisabilityin100communitycases offibromyalgiasyndromeversuscontrolsinLondon,Ontario: theLondonFibromyalgiaEpidemiologyStudy.ArthritisRheum. 1999;42(1):76-83.
11. Krag NJ, Norregaard J, Larsen JK, Danneskiold-Samsøe B. A blinded,controlledevaluationofanxietyanddepressivesymptoms inpatientswithfibromyalgia,asmeasuredbystandardizedpsycho-metricinterviewscales.ActaPsychiatrScand.1994;89(6):370-5. 12. MartinezJE,AtraE,FontanaAM,etal.Aspectospsicológicos
emmulherescomfibromialgia.[Psychologicalaspectsinwomen withfibromyalgia].RevBrasReumatol.1992;32(2):51-60. 13. YunusM,MasiAT,CalabroJJ,MillerKA,FeigenbaumSL.Primary
fibromyalgia(fibrositis):clinicalstudyof50patientswithmatched normalcontrols.SeminArthritisRheum.1981;11(1):151-71. 14.
BurckhardtCS,ClarkSR,BennettRM.Thefibromyalgiaim-pactquestionnaire:developmentandvalidation.JRheumatol. 1991;18(5):728-33.
15. WareJE,SherbourneCD.TheMOS36-itemshort-formhealth survey(SF-36).I.Conceptualframeworkanditemselection. MedCare.1992;30(6):473-83.
16. CiconelliRM.Traduçãoparaoportuguêsevalidaçãodoquestioná-riogenéricodeavaliaçãodaqualidadedevida“MedicalOutcomes Study36-ItemShort-FormHealthSurvey(SF-36)”.[thesis]São Paulo(SP):UniversidadeFederaldeSãoPaulo;1997. 17. BombardierC,MelfiCA,PaulJ,etal.Comparisonofagenericand
adisease-specificmeasureofpainandphysicalfunctionafterknee replacementsurgery.MedCare.1995;33(4Suppl):AS131-44. 18. Dias RC. Impacto de um protocolo de Fisioterapia sobre a
qualidadedevidadeidososcomosteoartritedejoelhos.[thesis] SãoPaulo(SP):UniversidadeFederaldeSãoPaulo;1999. 19. Spielberger DC, Gorsuch LR, Lushene ER. Inventário de
AnsiedadeTraço-Estado.RiodeJaneiro:Cepa;1979. 20. Pássaro AC. A identificação do nível de dor e ansiedade em
gestantes[monograph].SãoPaulo(SP):FaculdadedeMedicina, UniversidadedeSãoPaulo;1997.
21. GoldenbergDL,MosseyCJ,SchmidCH.Amodeltoassessseverity andimpactoffibromyalgia.JRheumatol.1995;22(12):2313-8. 22.
HawleyDJ,WolfeF.Pain,disability,andpain/disabilityrelation-shipsinsevenrheumaticdisorders:astudyof1.522patients.J Rheumatol.1991;18(10):1552-7.
23.MartinezJE,BaraunaFilhoIS,KubokawaKM,CevascoG, PedreiraIS,MachadoLAM.Avaliaçãodaqualidadedevida depacientescomfibromialgiaatravésdo“MedicalOutcome Survey 36 Item Short-Form Study”. Res Bras Reumatol. 1999;39:312-16.
24. MartinezJE,FerrazMB,SatoEI,AtraE.Avaliaçãoseqüencial doimpactofibromialgiaeartritereumatóidenaqualidadede vida.[Sequentialevaluationoftheimpactoffibromyalgiaand rheumatoidarthritisinthequalityoflife].RevBrasReumatol. 1994;34(6):309-16.
25. White KP, NielsonWR, Harth M, OstbyeT, Speechley M. Chronic widespread musculoskeletal pain with or without
fibromyalgia:psychologicaldistressinarepresentativecommu-nityadultsample.JRheumatol.2002;29(3):588-94. 26.BennettRM,BurckhardtCS,ClarkSR,O’ReillyCA,Wiens
AN,CampbellSM.Grouptreatmentoffibromyalgia:a6-month outpatientprogram.JRheumatol.1996;23(3):521-8. 27. GowansSE,deHueckA,VossS,RichardsonM.Arandomized,
controlledtrialofexerciseandeducationforindividualswith fibromyalgia.ArthritisCareRes.1999;12(2):120-8. 28.
BurckhardtCS,MannerkorpiK,HedenbergL,BjelleA.Arandom-ized,controlledclinicaltrialofeducationandphysicaltrainingfor womenwithfibromyalgia.JRheumatol.1994;21(4):714-20. 29. GowansSE,deHueckA,VossS,SilajA,AbbeySE,Reynolds
WJ.Effectofarandomized,controlledtrialofexerciseonmood andphysicalfunctioninindividualswithfibromyalgia.Arthritis Rheum.2001;45(6):519-29
30.ValimV.Estudodosefeitosdocondicionamentoaeróbioe doalongamentonafibromialgia.[Thisstudywastocom-pareflexibilitywithaerobicphysicalfitnessandimproving symptoms].[thesis]SãoPaulo(SP):UniversidadeFederalde SãoPaulo;2001.
31. MengshoelAM,HaugenM.Healthstatusinfibromyalgia–a followupstudy.JRheumatol.2001;28(9):2085-9. 32.BuskilaD,NeumannL,AlhoashleA,Abu-ShakraM.Fibromyalgia
syndromeinmen.SeminArthritisRheum.2000;30(1):47-51. 33. GowansSE,DeHueckA,AbbeySE.Measuringexercise-induced
moodchangesinfibromyalgia:acomparisonofseveralmeasures. ArthritisRheum.2002;47(6):603-9.
34. Schlenk EA, Erlen JA, Dunbar-Jacob J, et al. Health-related qualityoflifeinchronicdisorders:acomparisonacrossstudies usingtheMOSSF-36.QualLifeRes.1998;7(1):57-65. 35.
MartinezJE,BaraunaFilhoIS,KubokawaK,PedreiraIS,Mach-adoLA,CevascoG.EvaluationofthequalityoflifeinBrazilian womenwithfibromyalgia,throughthemedicaloutcomesurvey 36itemshort-formstudy.DisabilRehabil.2001;23(2):64-8. 36. GarrattAM,RutaDA,AbdallaMI,RussellIT.Responsivenessof
theSF-36andacondition-specificmeasureofhealthforpatients withvaricoseveins.QualLifeRes.1996;5(2):223-34. 37. GliklichRE,HilinskiJM.Longitudinalsensitivityofageneric
andspecifichealthmeasuresinchronicsinusitis.QualLifeRes. 1995;4(1):27-32.
PUBLISHINGINFORMATION
Firstpresentedatthe14thInternationalCongressofWorld
PhysicalTherapy,June9,2003,Barcelona,Spain.
Tathiana Pagano. Physiotherapist, Department of Phy-siotherapy, Phonoaudiology and Occupational Therapy, FaculdadedeMedicinadaUniversidadedeSãoPaulo, SãoPaulo,Brazil.
LucianaAkemiMatsutani,MSc.Professor,Department ofPhysiotherapy,CentroUniversitárioFundaçãoInstitutode EnsinoparaOsasco,Osasco,SãoPaulo,Brazil.
ElisabethAlvesGonçalvesFerreira,MSc.Professor ofthephysiotherapycourse,UniversidadeMetodistaand Centro Universitário Fundação Instituto de Ensino para Osasco,Osasco,SãoPaulo,Brazil.
Amélia Pasqual Marques,MD, PhD.Departmentof Physiotherapy, Phonoaudiology and Occupational The-rapy, Faculdade de Medicina da Universidade de São Paulo,SãoPaulo,Brazil.
CarlosAlbertoPereira,MD,PhD.ProfessorofStatistics, InstitutodeMatemáticaeEstatística,UniversidadedeSão Paulo,SãoPaulo,Brazil.
Sourcesoffunding:FAPESP–Grant#01/00484-0
Conflictofinterest:None
Dateoffirstsubmission:October6,2003
Lastreceived:July26,2004
Accepted:July28,2004
Addressforcorrespondence:
TathianaPagano
RuaTraituba,267—Saúde
SãoPaulo(SP)—Brasil—CEP04142-050 Tel.(+5511)5078-6461
Cell.(+5511)9157-1325 E-mail:[email protected]
COPYRIGHT©2004,AssociaçãoPaulistadeMedicina
Avaliaçãodaansiedadeequalidadedevidaem pacientesfibromiálgicos
CONTEXTO:
Fibromialgiaéumasíndromereumá-ticacaracterizadapordoresmúsculo-esqueléticas difusasecrônicasesítiosdolorososespecíficosà palpação,chamadosdetenderpoints ,freqüente-menteassociadosafadiga,distúrbiosdosono, rigidez matinal e, em alguns casos, dispnéia eansiedade.Devidoaoseucarátercrônico,a síndromegeralmentecausaimpactonegativona qualidadedevidadosfibromiálgicos.
OBJETIVO:Compararaeficáciadeinstrumentos
queavaliamaqualidadedevidadefibromi-álgicosmensuradapeloFibromyalgiaImpact Questionnaire(FIQ)epeloMedicalOutcomes Study 36-item Short-Form Healthy Survey (SF-36),eaansiedadeavaliadapeloInventário deAnsiedadeTraço-estado(IDATE).
TIPODEESTUDO:Transversal.
LOCAL:
AmbulatóriodeReumatologiadoHospi-taldasClínicasdaFaculdadedeMedicinada UniversidadedeSãoPaulo(HC/FMUSP).
MÉTODOS:Participaramdoestudo80sujeitos:40
comfibromialgia(grupoteste)e40saudáveis (grupocontrole).Trêsquestionários(doispara avaliaçãodequalidadedevida–FIQeSF-36–; eumparaansiedade–IDATE)foramaplicados aosindivíduosdosdoisgruposemumaúnica entrevista.Todaaanáliseestatísticafoirealizada utilizando-seoTeste“t”Studenteotestede CorrelaçãodePearson(r),comsignificância p<0,05.Alémdisso,otesteestatísticoQui-quadrado de Pearson, para homogeneidade, foiusadoparacompararograudeescolaridade entreosgrupostesteecontrole.
RESULTADOS:Osresultadosobtidosmostram
quehouvediferençaestatisticamentesignifi-canteentreosgrupos(p=0,00),indicandoque osfibromiálgicostêmpiorqualidadedevidae níveismaisaltosdeansiedade.Acorrelaçãoentre ostrêsquestionáriosfoialta(r=0,90).
DISCUSSÃO:Oimpactonegativonaqualidade
devidadecorrentedaFibromialgiatemsido
relatadoemmuitosestudos,nosquaisosproto-colosdeavaliaçãosãoosprincipaisistrumentos demedida.OFIQéuminstrumentoutilizado emváriosestudosclínicosparaavaliarafunção física.Esteestudocomprovouaeficiênciado FIQ para avaliar o impacto da fibromialgia sobreaqualidadedevida.OSF-36émenos específicoqueoFIQ,mastambémsemostrou eficienteparaaavaliaçãodaqualidadedevida defibromiálgicos,umavezqueosdiscrimina dosindivíduossaudáveis.Aansiedadeéconside-radaumsintomasecundáriodafibromialgiaeé freqüentementegravenoscasosdefibromialgia. Umdosinstrumentosutilizadosparaavaliá-laéo IDATE.Nopresenteestudo,apesardeapresentar resultadosestatisticamentesignificantesquando analisadoisoladamente,oIDATEmostrou-se menoseficazqueosdemaisinstrumentospara distinguirogrupotestedocontrole.Tratando-se maisespecificamentedaqualidadedevida,foi possívelconfirmarqueogrupotesteapresenta piorqualidadedevidaquandocomparadoao controle.Issofoidemonstradopelosdoisins-trumentosutilizadosparaavaliaraqualidadede vida(FIQeSF-36).Quantoàansiedade,apesar doIDATEtersidooinstrumentomenoseficaz, pôde-seobservarresultadossignificantesnaava-liaçãodosgrupostesteecontrole,evidenciando queospacientescomfibromialgiaapresentam maiorníveldeansiedade,tantonoestadocomo notraço.Portanto,ospacientescomfibromialgia têmníveismaiselevadosdetensão,nervosismo, preocupaçãoeapreensão(avaliadospelaescalaA-estado);emaiorpropensãoàansiedade(avaliada pelaescalaA-traço).
CONCLUSÃO:Ostrêsinstrumentosutilizados
mostraramsereficazesparaavaliarpacientes
fibromiálgicos,porémoFIQmostrousero maiseficazparadiscriminareavaliaroim-pactodafibromialgianaqualidadedevida. Conclui-se que os pacientes fibromiálgicos têmpiorqualidadedevidaeníveismaisaltos deansiedade.
PALAVRAS-CHAVE:Fibromialgia.Qualidadede